Literature DB >> 2784315

Distinct binding sites for Ins(1,4,5)P3 and Ins(1,3,4,5)P4 in bovine parathyroid glands.

P Enyedi1, E Brown, G Williams.   

Abstract

We utilized high specific activity, [32P]-labelled ligands to measure the binding of Ins(1,3,4,5)P4 and Ins(1,4,5)P3 to membranes prepared from bovine parathyroid glands. [32P]Ins(1,3,4,5)P4 bound rapidly and reversibly to parathyroid membranes, and the binding data could be fitted by the interaction of the ligand with two sites, one with Kd = 6.8 x 10(-9) M and Bmax = 26 fmol/mg protein and a second, lower affinity site, with Kd = 4.1 x 10(-7) M and Bmax = 400 fmol/mg protein. InsP5 was 10-20 fold less potent than InsP4, and Ins(1,3,4)P3 and Ins(1,4,5)P3 were nearly 1000-fold less potent in displacing [32P]Ins(1,3,4,5)P4. [32P]Ins(1,4,5)P3, on the other hand, bound to a single class of sites with Kd = 7.6 x 10(-9) M and Bmax = 34 fmol/mg. While the binding of [32P]Ins(1,4,5)P3 increased markedly on raising pH from 5 to 8, the binding of [32P]Ins(1,3,4,5)P4 decreased by 75% over this range of pH. Thus, [32P]-labelled Ins(1,3,4,5)P4 and Ins(1,4,5)P3 may be used to identify distinct binding sites which may represent physiologically relevant intracellular receptors for InsP3 and InsP4 in parathyroid cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784315     DOI: 10.1016/0006-291x(89)92423-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Cellular physiology and pathophysiology of the parathyroid glands.

Authors:  G Akerström; J Rastad; S Ljunghall; P Ridefelt; C Juhlin; E Gylfe
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

2.  Purification of a high-affinity inositol 1,3,4,5-tetrakisphosphate receptor from brain.

Authors:  F Donié; G Reiser
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

3.  Characteristics of [3H]inositol(1,3,4,5)tetrakisphosphate recognition sites in human cerebellar membranes.

Authors:  A Garlind; R F Cowburn; C J Fowler
Journal:  J Neural Transm Gen Sect       Date:  1995

4.  Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum.

Authors:  R A Challiss; A L Willcocks; B Mulloy; B V Potter; S R Nahorski
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

5.  Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay.

Authors:  R A Challiss; E R Chilvers; A L Willcocks; S R Nahorski
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

6.  Inositol 1,3,4,5-tetrakisphosphate stimulates calcium release from bovine adrenal microsomes by a mechanism independent of the inositol 1,4,5-trisphosphate receptor.

Authors:  J A Ely; L Hunyady; A J Baukal; K J Catt
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

7.  Inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate binding sites in smooth muscle.

Authors:  L Zhang; M E Bradley; M Khoyi; D P Westfall; I L Buxton
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Inositol 1,3,4,5-tetrakisphosphate binding sites in neuronal and non-neuronal tissues. Properties, comparisons and potential physiological significance.

Authors:  P J Cullen; R F Irvine
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

9.  Specific binding sites for inositol 1,3,4,5-tetrakisphosphate are located predominantly in the plasma membranes of human platelets.

Authors:  P J Cullen; Y Patel; V V Kakkar; R F Irvine; K S Authi
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.